Avalon GloboCare Receives Allowance for Joint U.S. Patent
Provided By Globe Newswire
Last update: Sep 29, 2022
FREEHOLD, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today provided an update regarding the Company’s intellectual property portfolio featuring its QTY protein code technology.
